Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$112M |
| 2 |
Ferguson
FERG
|
+$104M |
| 3 |
Amazon
AMZN
|
+$101M |
| 4 |
Apple
AAPL
|
+$98.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$75M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$52.5M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$38.1M |
| 5 |
Equity Residential
EQR
|
+$22.8M |
Sector Composition
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Communication Services | 10.9% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Krystal Biotech
KRYS
$4.16B
| $2.26M | ﹤0.01% |
29,300
+400
| +1% | +$30.8K |
|
1927
Omeros
OMER
$282M
| $2.26M | ﹤0.01% |
126,800
+1,500
| +1% | +$26.7K |
|
|
DBD
1928
DELISTED
Diebold Nixdorf Incorporated
DBD
| $2.26M | ﹤0.01% |
159,659
+1,300
| +0.8% | +$18.4K |
|
1929
RLX Technology
RLX
$3.23B
| $2.25M | ﹤0.01% |
+217,550
| New | +$2.25M |
|
1930
Impinj
PI
$5.37B
| $2.25M | ﹤0.01% |
39,600
+1,100
| +3% | +$62.6K |
|
1931
Chefs' Warehouse
CHEF
$2.7B
| $2.24M | ﹤0.01% |
73,400
+800
| +1% | +$24.4K |
|
1932
Smith & Wesson
SWBI
$420M
| $2.23M | ﹤0.01% |
127,750
+2,900
| +2% | +$50.6K |
|
1933
Dynavax Technologies
DVAX
$1.12B
| $2.23M | ﹤0.01% |
226,578
+3,700
| +2% | +$36.4K |
|
1934
Kearny Financial
KRNY
$415M
| $2.22M | ﹤0.01% |
184,064
+1,900
| +1% | +$22.9K |
|
|
RDUS
1935
DELISTED
Radius Health, Inc.
RDUS
| $2.22M | ﹤0.01% |
106,400
+1,300
| +1% | +$27.1K |
|
1936
Children's Place
PLCE
$161M
| $2.21M | ﹤0.01% |
31,700
+400
| +1% | +$27.9K |
|
1937
QuinStreet
QNST
$927M
| $2.21M | ﹤0.01% |
108,800
+1,600
| +1% | +$32.5K |
|
|
NXGN
1938
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.21M | ﹤0.01% |
122,000
+1,400
| +1% | +$25.3K |
|
1939
Angi Inc
ANGI
$783M
| $2.2M | ﹤0.01% |
16,910
+1,100
| +7% | +$143K |
|
1940
Agilysys
AGYS
$3.02B
| $2.2M | ﹤0.01% |
45,800
+500
| +1% | +$24K |
|
|
RUBY
1941
DELISTED
Rubius Therapeutics, Inc
RUBY
| $2.2M | ﹤0.01% |
82,900
+10,000
| +14% | +$265K |
|
|
MCHB
1942
Mechanics Bancorp Class A Common Stock
MCHB
$3.08B
| $2.2M | ﹤0.01% |
49,800
-1,500
| -3% | -$66.1K |
|
1943
PagerDuty
PD
$1.53B
| $2.19M | ﹤0.01% |
54,500
+1,200
| +2% | +$48.3K |
|
1944
e.l.f. Beauty
ELF
$7.77B
| $2.19M | ﹤0.01% |
81,700
+1,400
| +2% | +$37.6K |
|
1945
National Healthcare
NHC
$1.78B
| $2.19M | ﹤0.01% |
28,130
+300
| +1% | +$23.4K |
|
|
TGI
1946
DELISTED
Triumph Group
TGI
| $2.19M | ﹤0.01% |
119,100
+1,400
| +1% | +$25.7K |
|
1947
Customers Bancorp
CUBI
$2.32B
| $2.18M | ﹤0.01% |
68,600
+700
| +1% | +$22.3K |
|
1948
RadNet
RDNT
$5.66B
| $2.18M | ﹤0.01% |
100,300
+1,200
| +1% | +$26.1K |
|
1949
Rackspace Technology
RXT
$357M
| $2.18M | ﹤0.01% |
91,600
+1,600
| +2% | +$38K |
|
1950
Preferred Bank
PFBC
$1.16B
| $2.17M | ﹤0.01% |
34,089
+700
| +2% | +$44.6K |
|